News tagged with food and drug administration
Related topics: drug , fda , centers for disease control and prevention , heart attack , patients
Rules must evolve to allow new drugs for early Alzheimer's
(HealthDay)—Given the shift in the focus of drug development for Alzheimer's disease toward earlier disease stages, before the onset of dementia, regulatory guidelines need to evolve, according to a perspective ...
Alzheimer's disease & dementia
Mar 14, 2013 |
4 / 5 (2) |
0
US probes new pancreas risks with diabetes drugs (Update)
The U.S. Food and Drug Administration is looking into new evidence that suggests a group of recently approved diabetes drugs can increase the risk of pancreatitis and other problems.
Medications
Mar 14, 2013 |
not rated yet |
0
Researchers argue for a 'new paradigm' in the world of healthcare
(Medical Xpress)—Two innovative programs designed to improve the availability of emerging medical technologies that can help patients receive more effective, efficient and personalized health care are advanced in a commentary ...
Health
Mar 14, 2013 |
not rated yet |
0
|
Lymphoseek approved to help locate lymph nodes
(HealthDay)—The injected imaging drug Lymphoseek (technetium Tc 99m tilmanocept) has been approved by the U.S. Food and Drug Administration to help surgeons locate the lymph nodes among people with breast cancer or melanoma.
Cancer
Mar 13, 2013 |
not rated yet |
0
Tobacco industry appears to have evaded FDA ban on 'light' cigarette descriptors
New research from Harvard School of Public Health (HPSH) shows that one year after the federal government passed a law banning word descriptors such as "light," "mild," and "low" on cigarette packages, smokers can still easily ...
Health
Mar 13, 2013 |
5 / 5 (1) |
0
FDA adds heart risk warning to popular antibiotic Zithromax
The Food and Drug Administration is warning doctors and patients that a widely used antibiotic from Pfizer can cause rare but deadly heart rhythms in some patients.
Medications
Mar 12, 2013 |
not rated yet |
0
Hard to find good info on drug safety in pregnancy
Nearly every woman takes a medication at some point during pregnancy. Yet there's disturbingly little easy-to-understand information about which drugs pose a risk to her baby, and what to do about it.
Medications
Mar 12, 2013 |
not rated yet |
0
FDA encourages opioid prescribers to pursue training
(HealthDay)—Prescribers of extended-release/long-acting (ER/LA) opioid analgesics are encouraged to participate in continuing medical education (CME) provided by manufacturers of these analgesics, according ...
Medications
Mar 12, 2013 |
not rated yet |
0
Food for thought: Panel discusses how labeling products could be improved
Food labels appear mundane enough, but the tug of war playing out behind them about what's on them is anything but.
Health
Mar 12, 2013 |
4 / 5 (1) |
0
FDA head says menu labeling 'thorny' issue
(AP)—Diners will have to wait a little longer to find calorie counts on most restaurant chain menus, in supermarkets and on vending machines.
Health
Mar 12, 2013 |
not rated yet |
0
US probes Sanofi over blockbuster drug Plavix (Update 2)
The U.S. Justice Department is investigating drug maker Sanofi's disclosures to the Food and Drug Administration about different responses to its blockbuster blood thinner Plavix.
Medications
Mar 11, 2013 |
not rated yet |
0
Study: Mega vitamins won't help after heart attack, chelation treatment might
(HealthDay)—There's mixed news from a much-anticipated clinical trial for people who've suffered a heart attack: While a study found that daily high doses of vitamins and minerals did nothing to improve ...
Cardiology
Mar 11, 2013 |
1 / 5 (1) |
0
|
Cochrane group skeptical about latest Roche pledges
(HealthDay)—Following requests from Cochrane researchers, Roche has pledged to release full clinical study reports for Tamiflu, although there appear to be conditions attached, according to correspondence ...
Medications
Mar 07, 2013 |
not rated yet |
0
Steer clear of 'miracle cures,' other bogus health products: FDA
(HealthDay)—Fraudulent health products are commonplace and can cause serious injury or even death, the U.S. Food and Drug Administration warns.
Medications
Mar 06, 2013 |
not rated yet |
0
US panel sees risk in long-used osteoporosis drug
A panel of U.S. government health experts says a long-established bone strengthening drug should no longer be used by women because there is little evidence it works and it may actually increase the risk of cancer.
Medications
Mar 05, 2013 |
5 / 5 (1) |
0
